Supplemental material
Open access
13,640
Views
36
CrossRef citations to date
0
Altmetric
Articles
Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy
David LundgrenDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
, Vincy EklöfDepartment of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden; View further author information
, Richard PalmqvistDepartment of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden; View further author information
, Johan HultdinDepartment of Medical Biosciences Division of Clinical Chemistry, Umeå University, SwedenView further author information
& Pontus KarlingDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; Correspondence[email protected]
http://orcid.org/0000-0002-5607-0118View further author information
http://orcid.org/0000-0002-5607-0118View further author information
Pages 152-157
|
Received 04 Nov 2018, Accepted 16 Dec 2018, Published online: 24 Jan 2019
Related Research Data
Antioxidant properties of omeprazole.
Source:
Published by Elsevier B.V.
An irritable bowel syndrome-specific symptom questionnaire: development and validation.
Source:
Informa UK Limited
Non-steroidal anti-inflammatory drug-induced enteropathy
Source:
Korean Association for the Study of Intestinal Diseases
Fecal calprotectin for mucosal healing
Source:
Wiley
Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.
Source:
Informa UK Limited
Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
Source:
Korean Society for Laboratory Medicine (KAMJE)
Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.
Source:
Ovid Technologies (Wolters Kluwer Health)
Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.
Source:
Ovid Technologies (Wolters Kluwer Health)
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
Source:
Ovid Technologies (Wolters Kluwer Health)
A Link between Lifestyle Factors and Colorectal Cancer Risk
Source:
American Association for Cancer Research (AACR)
Proton pump inhibitors and gastroenteritis
Source:
Springer Science and Business Media LLC
Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum
Source:
Informa UK Limited
Fecal Calprotectin Levels in Patients with Colonic Polyposis
Source:
Springer Science + Business Media
Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
Source:
Baishideng Publishing Group Inc.
Low-dose aspirin-induced gastrointestinal diseases: past, present, and future.
Source:
Springer Science and Business Media LLC
Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy.
Source:
Ovid Technologies (Wolters Kluwer Health)
A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
Source:
Elsevier BV
Calprotectin in Daily Practice: Where Do We Stand in 2017?
Source:
S. Karger AG
Can chronic gastritis cause an increase in fecal calprotectin concentrations
Source:
Baishideng Publishing Group Inc.
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats
Source:
Baishideng Publishing Group Inc.
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
Source:
Oxford University Press (OUP)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.